CA 12–5 Serum Levels and Histological Findings at Second Look in Patients With Ovarian Cancer

Journal of Cancer Research and Clinical Oncology - Germany
doi 10.1007/bf02580309
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Prognostic Significance of Interleukin 6 Serum Levels in Patients With Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1995English

Preoperative Differentiation Between Malignant and Benign Ovarian Masses in Patients With Normal CA-125 Levels

Gynecology Obstetrics & Reproductive Medicine
2016English

Results of Second-Look Laparotomy in Advanced Ovarian Cancer: One Single Center Experience

ISRN Obstetrics and Gynecology
2012English

Platin-Based Chemotherapy and Salvage Surgery in Recurrent Ovarian Cancer Following Negative Second-Look Laparotomy

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
1998English

Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Serum Protein Profiles of Patients With Lung Cancer of Different Histological Types

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2015English

Elevated Serum CA 19-9 Levels in Dermoid Cyst: A Predictor of Ovarian Torsion and Tissue Necrosis?

International Journal of Reproduction, Contraception, Obstetrics and Gynecology
2019English

A Second Look at AJOT's "New Look"

American Journal of Occupational Therapy
MedicineOccupational Therapy
1980English

CA 125 Half-Life Breakpoint Between a “Good” and “Poor” Prognosis in Patients With Ovarian Cancer

International Journal of Gynecology and Obstetrics
MedicineGynecologyObstetrics
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy